A new report by STAT sheds additional light on how drugmakers relentlessly abuse the patent system. The report comes as drugmakers continue to wage lavishly funded campaigns to demonize negotiators in both the private sector and the government so they can continue to overcharge Americans for prescription drugs.

Full story: https://www.statnews.com/pharmalot/2024/09/18/pharmaceuticals-prescription-drug-patents-prices-orange-book